FOOTHILL
RANCH, Calif., Aug. 31,
2021 /PRNewswire/ -- Today BIOLASE, Inc.
(NASDAQ: BIOL), the global leader in dental lasers, announced a
clinical advisory partnership with Dr. L. Stephen Buchanan that will help expand laser
adoption and increase hands-on training programs with one of the
global leaders in endodontics.
Dr. Buchanan has lectured and taught hands-on endodontic
continuing education courses for over 30 years, both at DELabs, his
state-of-the-art training facility in Santa Barbara, Calif., as well as in dental
schools and symposiums around the world. He is a part-time faculty
member in the endodontic departments at University of the Pacific's Arthur A. Dugoni School of Dentistry and at UCLA
School of Dentistry. He maintains a private practice limited to
Endodontics in Santa Barbara,
Calif., and is a Diplomate of the American Board of
Endodontists and a Fellow of the International and American
Colleges of Dentists.
"BIOLASE is elevating the standard of care in endodontics with
their Er,Cr:YSGG Waterlase device," said Dr. Buchanan. "This
technology supports single-visit RCT and minimally-invasive
endodontic procedures as it very effectively cavitates
sodium hypochlorite in our smallest preparations."
"We are proud to be partnering with Dr. Buchanan because of his
reputation as an expert in the research and development of new
technology, instruments, and techniques in endodontics," said
John Beaver, BIOLASE President
and CEO. "This partnership provides the most advanced laser
technology in Endodontics for Dr. Buchanan's practice and training
programs."
Learn more about the benefits of laser dentistry in endodontics
at biolase.com.
About BIOLASE
BIOLASE is a medical device company that develops, manufactures,
markets, and sells laser systems in dentistry and medicine.
BIOLASE's products advance the practice of dentistry and medicine
for patients and healthcare professionals. BIOLASE's proprietary
laser products incorporate approximately 271 patented and 40
patent-pending technologies designed to provide biologically and
clinically superior performance with less pain and faster recovery
times. BIOLASE's innovative products provide cutting-edge
technology at competitive prices to deliver superior results for
dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications. BIOLASE has sold over 41,200 laser systems to date in
over 80 countries around the world. Laser products under
development address BIOLASE's core dental market and other adjacent
medical and consumer applications.
For updates and information on Waterlase® and
laser dentistry, find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram
at www.instagram.com/waterlase_laserdentistry, and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE® and Waterlase® are registered trademarks of BIOLASE,
Inc.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-announces-clinical-advisory-partnership-with-leading-endodontist-dr-l-stephen-buchanan-301365614.html
SOURCE BIOLASE, Inc.